TriangleFOR PATIENTS · SOURCE READING
Hormone therapy
Source: Gastrointestinal Neuroendocrine Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 20, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview / The following types of treatment are used:
Hormone therapy with a somatostatin analog is a treatment that stops extra hormones from being made. GI neuroendocrine tumors are treated with octreotide or lanreotide which are injected under the skin or into the muscle. Octreotide and lanreotide may also have a small effect on stopping tumor growth.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice